Through RT–PCR, we found that in the hilar cholangiocarcinoma, control and sham operation groups, the FXR/Gapdh ratios were 17 ± 1.3, 39 ± 1.6 and 38 ± 1.5, respectively. This evidence concerns the gene NR1H4 and hilar cholangiocarcinoma.